Skip to main content
Equibles
NPCE logo

NPCE · NeuroPace Inc · Metrics

Track NPCE — free

Use NPCE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NPCE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.50 -0.26 (-1.76%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$497.70M
Shares
34.32M

NPCE metrics

67 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.50
Market cap
$497.70M

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
-0.8%
Price change (3M)
-7.5%
Price change (6M)
+3.8%
Price change (YTD)
-4.4%
Price change (1Y)
+52.0%
Trailing year
Price change (5Y)
-33.0%
52-week high
$19.29
52-week low
$9.40
Change from 52-week high
-23.5%
Change from 52-week low
+57.0%
Annualized volatility
62.4%
Annualized volatility (3M)
51.4%
Beta
1.4
RSI (14D)
51.1
Price vs SMA 50
-2.1%
Price vs SMA 200
-4.7%
Avg volume (3M)
186,822
Relative volume
0.6
Average dollar volume
$2.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
34.32M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.8×
reciprocal yield 20.7%
P / book
41.9
reciprocal yield 2.4%
FCF yield
-2.3%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
78.4%
Operating margin
-13.3%
Trailing 12 months
Net margin
-18.6%
Gross profit (TTM)
$80.62M
Operating profit (TTM)
−$13.71M
Net income (TTM)
−$19.11M
Trailing 12 months
Diluted EPS (TTM)
$-0.57
FCF margin
-11.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.57

Growth

11 metrics
Revenue growth YoY
+17.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$102.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
+30.0%
Revenue CAGR (5Y)
+19.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-160.9%
Return on assets
-19.7%
Debt / equity
—
Current ratio
4.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$11.61M
Quick ratio
3.9
Interest coverage
-2.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$12.54M
Total assets
$96.99M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$11.24M
Capital expenditures (TTM)
$369,000
R&D (TTM)
$27.69M
SG&A (TTM)
$57.05M
Stock compensation (TTM)
$9.82M
R&D / revenue
26.9%
Stock compensation / revenue
9.5%

Ownership (13F)

3 metrics
13F filers
112
13F filer change QoQ
-1
Institutional ownership
77.4%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1528287 CUSIP 641288105 13F (30d) 81 filings 81 filers Visit website Investor relations